SEHK:722

Stock Analysis Report

UMP Healthcare Holdings

Executive Summary

UMP Healthcare Holdings Limited, an investment holding company, provides a range of healthcare services in Hong Kong, Macau, and Mainland China.

Snowflake

Fundamentals

Flawless balance sheet with moderate growth potential.

Share Price & News

How has UMP Healthcare Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

4.0%

722

4.2%

HK Healthcare

3.1%

HK Market


1 Year Return

-7.6%

722

-25.0%

HK Healthcare

0.5%

HK Market

Return vs Industry: 722 exceeded the Hong Kong Healthcare industry which returned -25% over the past year.

Return vs Market: 722 underperformed the Hong Kong Market which returned 0.5% over the past year.


Shareholder returns

722IndustryMarket
7 Day4.0%4.2%3.1%
30 Day29.8%-1.3%-1.8%
90 Day15.4%-3.2%-4.8%
1 Year-6.1%-7.6%-23.4%-25.0%4.1%0.5%
3 Year29.1%22.7%-32.4%-36.4%15.8%4.2%
5 Yearn/a-29.9%-36.0%18.9%-0.9%

Price Volatility Vs. Market

How volatile is UMP Healthcare Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is UMP Healthcare Holdings undervalued compared to its fair value and its price relative to the market?

91.77x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Undervalued: 722 (HK$1.57) is trading above our estimate of fair value (HK$0.5)

Significantly Undervalued: 722 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 722 is poor value based on its PE Ratio (91.8x) compared to the Healthcare industry average (16x).

PE vs Market: 722 is poor value based on its PE Ratio (91.8x) compared to the Hong Kong market (10.3x).


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate 722's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 722 is overvalued based on its PB Ratio (1.9x) compared to the HK Healthcare industry average (1.4x).


Next Steps

Future Growth

How is UMP Healthcare Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

21.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 722's forecast earnings growth (21% per year) is above the savings rate (2%).

Earnings vs Market: 722's earnings (21% per year) are forecast to grow faster than the Hong Kong market (11.3% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 722's revenue is forecast to grow faster than the Hong Kong market.

High Growth Revenue: Insufficient data to determine if 722's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: Insufficient data to determine if 722's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has UMP Healthcare Holdings performed over the past 5 years?

-8.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: 722's earnings have declined by -8.9% per year over the past 5 years.

Accelerating Growth: 722's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 722 had negative earnings growth (-65.9%) over the past year, making it difficult to compare to the Healthcare industry average (5.6%).


Return on Equity

High ROE: 722's Return on Equity (2.8%) is considered low.


Return on Assets

ROA vs Industry: 722's Return on Assets is below or equal to the Healthcare industry average last year.


Return on Capital Employed

ROCE Improving: 722's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is UMP Healthcare Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 722's short term assets (HK$371.0M) exceeds its short term liabilities (HK$138.7M)

Long Term Liabilities: 722's short term assets (371.0M) exceeds its long term liabilities (17.4M)


Debt to Equity History and Analysis

Debt Level: 722 is debt free.

Reducing Debt: 722 has not had any debt for past 5 years.

Debt Coverage: 722 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 722 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: 722 has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if 722's debt is covered by short term assets.


Next Steps

Dividend

What is UMP Healthcare Holdings's current dividend yield, its reliability and sustainability?

2.04%

Current Dividend Yield


Upcoming Dividend Payment

Purchase UMP Healthcare Holdings before the 'Buy Limit' to receive their next dividend payment.


Dividend Yield vs Market

company2.0%marketbottom25%2.3%markettop25%6.3%industryaverage2.6%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: 722's dividend (2.04%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (2.27%).

High Dividend: 722's dividend (2.04%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.25%).

Stable Dividend: 722 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 722's dividend payments have increased, but the company has only paid a dividend for 3 years.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (187%), 722's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

What is the CEO of UMP Healthcare Holdings's salary, the management and board of directors tenure and is there insider trading?

4.2yrs

Average management tenure


CEO

Yiu Kwong Sun (76yo)

4.2yrs

Tenure

HK$8,111,000

Compensation

Dr. Yiu Kwong Sun has been Chief Executive Officer at UMP Healthcare Holdings Limited since August 29, 2015, Executive Director since April 23, 2015 and serves as its Chairman. Dr. Sun is primarily respons ...


CEO Compensation Analysis

Compensation vs. Market: Yiu Kwong's total compensation ($USD1.03M) is about average for companies of similar size in the Hong Kong market ($USD212.13K).

Compensation vs Earnings: Yiu Kwong's compensation has been consistent with company performance over the past year.


Management Age and Tenure

4.2yrs

Average Tenure

51yo

Average Age

Experienced Management: 722's management team is considered experienced (4.2 years average tenure).


Board Age and Tenure

3.9yrs

Average Tenure

55yo

Average Age

Experienced Board: 722's board of directors are considered experienced (3.9 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Patrick Tsang (47yo)

    Executive Director

    • Tenure: 4.2yrs
    • Compensation: HK$222.00k
  • Felix Lee (37yo)

    Executive Director

    • Tenure: 0yrs
    • Compensation: HK$3.04m
  • Yiu Kwong Sun (76yo)

    Chairman & CEO

    • Tenure: 4.2yrs
    • Compensation: HK$8.11m
  • Jacquen Kwok (51yo)

    MD & Executive Director

    • Tenure: 4.9yrs
    • Compensation: HK$4.75m
  • Michael Sun (41yo)

    Executive Director

    • Tenure: 0yrs
    • Compensation: HK$222.00k
  • Hoi Wan Ma (44yo)

    Financial Controller & Company Secretary

    • Tenure: 9.5yrs
  • Po Ming Wong (52yo)

    Head of Business

    • Tenure: 9.4yrs
  • Blanche Wong (54yo)

    Chief Nursing Officer of China and Head of Medical Centre Chain Management Department

    • Tenure: 4.2yrs
  • Patrick Lee (55yo)

    Executive Director

    • Tenure: 1.7yrs
    • Compensation: HK$71.00k
  • Chi Sai Leung

    Consultant

    • Tenure: 0yrs

Board Members

  • John Lee (70yo)

    Independent Non-Executive Director

    • Tenure: 3.9yrs
    • Compensation: HK$250.00k
  • Patrick Tsang (47yo)

    Executive Director

    • Tenure: 4.2yrs
    • Compensation: HK$222.00k
  • Mike Yeung (66yo)

    Independent Non-Executive Director

    • Tenure: 3.9yrs
    • Compensation: HK$200.00k
  • Felix Lee (37yo)

    Executive Director

    • Tenure: 0yrs
    • Compensation: HK$3.04m
  • Yiu Kwong Sun (76yo)

    Chairman & CEO

    • Tenure: 4.2yrs
    • Compensation: HK$8.11m
  • Jacquen Kwok (51yo)

    MD & Executive Director

    • Tenure: 4.9yrs
    • Compensation: HK$4.75m
  • Michael Sun (41yo)

    Executive Director

    • Tenure: 0yrs
    • Compensation: HK$222.00k
  • Donald Li (65yo)

    Independent Non-Executive Director

    • Tenure: 3.9yrs
    • Compensation: HK$200.00k
  • Patrick Lee (55yo)

    Executive Director

    • Tenure: 1.7yrs
    • Compensation: HK$71.00k

Company Information

UMP Healthcare Holdings Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: UMP Healthcare Holdings Limited
  • Ticker: 722
  • Exchange: SEHK
  • Founded: 1990
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: HK$1.144b
  • Shares outstanding: 757.82m
  • Website: https://www.ump.com.hk

Number of Employees


Location

  • UMP Healthcare Holdings Limited
  • Wing On House
  • Room 1404–1408
  • Central
  • Hong Kong

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
722SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary sharesHKHKDNov 2015

Biography

UMP Healthcare Holdings Limited, an investment holding company, provides a range of healthcare services in Hong Kong, Macau, and Mainland China. The company operates through two segments, Corporate Healthc ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/17 12:55
End of Day Share Price2019/10/17 00:00
Earnings2019/06/30
Annual Earnings2019/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.